Cartography Bio Corrals $67M to Bring Targeted Colorectal Cancer Drug Into the Clinic
Colorectal cancer patients whose disease exhibits certain rare genetic signatures have the option of treatment with immunotherapies. But these targeted cancer treatments haven’t worked for patients with the two subtypes that represent the majority of colorectal cancer cases. The technologies of Cartography Biosciences enable its scientists to find their way to the right targets for…